Quick Access to UHS MyChart

Free and secure access to your UHS healthcare team and services.

Urgent News/Direction

Gov. Hochul announces 20 new #VaxToSchool pop-up sites - 9/30/21

120 Sites to Be Established Statewide Over 12 Weeks to Increase Vaccination Rates Among School-Aged New Yorkers 
New Sites to Be Announced Weekly Over The 12-Week Period; Full List of Sites Will Be Updated Weekly Here 
Governor Kathy Hochul today announced 20 new #VaxtoSchool pop-up vaccination sites to increase vaccination rates among school-aged New Yorkers. On September 21, Governor Hochul announced a total of 120 sites will be established over a 12-week period statewide. The Department of Health is working with localities, community-based organizations, and healthcare centers on-the-ground to establish these sites in all regions of the state. Partners, host sites, and outreach efforts are tailored to the communities they are built to serve. New locations are established on a rolling basis, and more sites will be announced each week over the 12-week period. 
"Parents and guardians—don't wait to get your child vaccinated," Governor Hochul said. "The COVID-19 vaccine is safe, effective, and the best way to keep eligible school-aged New Yorkers and our school communities protected from the virus. As part of our broader #VaxtoSchool effort, these new pop-up sites will bring the vaccine to communities across the state to make sure it's accessible to all New York families." 
This announcement builds on New York State's commitment to making the health and well-being of students, teachers and families a top priority. As of September 29, 60.4 percent of 12 to 15-year-olds and 70.1 percent of 16 to 25-year-olds have received at least one vaccine dose. 
Operational days for each of the #VaxtoSchool pop-up vaccination sites for school-aged New Yorkers are below. The full list of #VaxtoSchool sites is available here and will be updated weekly over the 12-week period to include new sites when they are announced. New locations are established on a rolling-basis, and more sites will be announced each week over the 12-week period. 
East Flatbush - Life of Hope 
1377 Brooklyn Ave 
Brooklyn, NY 11203 
Open: Thursday, September 30; 11:00 am - 5:30 pm 
Vaccine Type: Pfizer-BioNTech 
Yonkers Public Library 
1500 Central Park Ave 
Yonkers, NY 10710 
Open: Friday, October 1; 10:00 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech 
WNY Women's Foundation and Harvest House to host an Upskill and Wellness Symposium 
175 Jefferson Ave 
Buffalo, NY 14210 
*For members only 
Open: Friday, October 1; 5:00 pm - 8:00 pm 
Vaccine Type: Pfizer-BioNTech 
Mosholu Montefiore Community Center 
3450 Dekalb Avenue 
Bronx, NY 10467 
Open: Friday, October 1; 10:00 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech; Second shot POD 
Chenango Valley High School 
221 Chenango Bridge Rd 
Binghamton, NY 13901 
*For members Chenango Valley High School District only 
Open: Friday, October 1; 2:40 pm - 5:00 pm 
Vaccine Type: Pfizer-BioNTech and Janssen/J&J 
NW Rochester Prep 
899 Jay Street 
Rochester, NY 14611 
*For members NW Rochester Prep District only 
Open: Friday, October 1; 2:30 pm - 5:00 pm 
Vaccine Type: Pfizer-BioNTech 
Broome-Tioga BOCES Main Campus 
435 Glenwood Rd 
Binghamton, NY 13905 
*For members of the Broome-Tioga BOCES District only 
Open: Friday, October 1; 10:00 pm - 12:00 pm 
Vaccine Type: Pfizer-BioNTech and Janssen/J&J 
Mastic Beach Fire House 
1080 Mastic Road 
Mastic, NY 11950 
Open: Friday, October 1; 1:00 pm - 5:00 pm 
Vaccine Type: Pfizer-BioNTech 
Vertus Charter School 
21 Humboldt St 
Rochester, NY 14609 
*For members Vertus Charter School District only 
Open: Saturday, October 2; 10:00 am - 2:00 pm 
Vaccine Type: Pfizer-BioNTech and Janssen/J&J 
Lafayette High School/School #45 
370 Lafayette Ave 
Buffalo, NY 14213 
*For members Lafayette High School/School #45 District only 
Open: Saturday, October 2; 10:00 am - 1:00 pm 
Vaccine Type: Pfizer-BioNTech 
Grace Church Health Fair Mt. Vernon 
52 South 6th Ave 
Mount Vernon, NY, 10550 
Open: Saturday, October 2; 10:00 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech 
St. James Park 
2550 Jerome Ave 
Bronx, NY 10468 
Open: Saturday, October 2; 12:00 pm - 4:00 pm 
Vaccine Type: Pfizer-BioNTech 
Kingston High School 
403 Broadway 
Kingston, NY 12401 
*For members of the Kingston School District only 
Open: Saturday, October 2; 12:00 pm - 5:00 pm 
Vaccine Type: Pfizer-BioNTech 
Wallkill Senior High School 
90 Robinson Drive 
Wallkill, NY 12589 
*For members of the Walkill School District only 
Open: Sunday, October 3; 10:00 am - 3:00 pm 
Vaccine Type: Pfizer-BioNTech 
East Flatbush - Life of Hope, 
1377 Brooklyn Ave 
Brooklyn, NY 11203 
Open: Thursday, October 7; 11:00 am - 5:30 pm 
Vaccine Type: Pfizer-BioNTech and Janssen/J&J 
Ossining High School (Located in the Gymnasium) 
29 S. Highland Ave 
Ossining, NY 10562 
*For members of the Ossining School District only 
Open: Thursday, October 7; 3:30 pm - 6:30 pm 
Vaccine Type: Pfizer-BioNTech 
Variety Boys & Girls Club of Queens 
21-12 30th Road 
Astoria, NY 11102 
Open: Saturday, October 9; 10:00 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech; Second shot POD 
Child Development Support Corporation (CDSC)         
NYC Back 2 School Fair 
352 Classon Avenue (between Clifton Plaza & Lafayette Avenue) 
Brooklyn, NY 11238 
Open: Saturday, October 9; 11:00 am - 3:00 pm 
Vaccine Type: Pfizer-BioNTech 
Pilgrim Baptist Church, 80 N. Franklin Street 
Nyack, NY 10960 
Open: Saturday, October 9; 10:00 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech 
Tracey Towers - 40 W. Moshulu Parkway Building #20 
Bronx, NY 10468 
Open: Saturday, October 9; 8:30 am - 4:00 pm 
Vaccine Type: Pfizer-BioNTech 
Children aged 12 to 17 can take the Pfizer-BioNTech COVID-19 vaccine, which is available under Emergency Use Authorization for children ages 12 to 15 and is fully approved for those age 16 and older. The other COVID-19 vaccines are not yet authorized or approved for this age group. If you are a parent or guardian of a school-aged New Yorker, you can also visit vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233 to find a vaccine location closest to you. Make sure that the provider offers the Pfizer-BioNTech COVID-19 vaccine. 
To learn more about the COVID-19 vaccine and school-aged children, New Yorkers can visit our dedicated website ny.gov/vaxtoschool or follow @VaccinateNY on Instagram. 
Parents are encouraged to make sure their child is up to date on all recommended and required vaccinations. Please visit the Department of Health website for more information on recommended childhood and adolescent immunizations. 

Updated Return to Work Guidance from OPWDD - 9/3/21

OPWDD has released the below updated direct care staff return to work protocols:

Revised Protocols for Personnel in Clinical and Direct Care Settings to Return to Work Following COVID-19 Exposure or Infection

Find more guidance on COVID-19 at the following link:


Additionally, the CDC recently made the below COVID-19 resources available to staff who support people with developmental disabilities:

Talking to Patients with Intellectual and Developmental Disabilities about COVID-19 Vaccination

CDC launches COVID-19 resources for people with intellectual and developmental disabilities

Guidance for  the NYS COVID-19 Vaccination Program - 6/24/21

Emergency Declaration - Updated Guidance 6/28

The state of emergency has ended. The below guidance has been updated to reflect all the changes. 
NYSIIS: https://coronavirus.health.ny.gov/system/files/documents/2021/06/nysiis_and_cir_reporting_requirements_for_covid_vaccine_program_062421.pdf 
Clarifies that providers are still required to report all vaccinations to NYSIIS/CIR within 24 hours pursuant to the federal provider agreement.
POLS: https://coronavirus.health.ny.gov/system/files/documents/2021/06/pols_covid.pdf
Clarifies that physician office labs are still required to report COVID testing results to ECLRS within 24 hours of performing the test.
DAL: https://www.health.ny.gov/professionals/hospital_administrator/letters/   
Direct link: https://www.health.ny.gov/professionals/hospital_administrator/letters/2021/docs/dal_21-02.pdf    
Clarifies that temporary structures and changes to physical structures can remain for 6 months, and if needed longer than 6 months they must go through the Certificate of Need process.
PSC: https://coronavirus.health.ny.gov/system/files/documents/2021/06/patient_service_center_letter_06242021.pdf
Allows patient service centers to continue to collect specimens for 30 days while requests for DOH approval are in process.
LSL: https://coronavirus.health.ny.gov/system/files/documents/2021/06/pharmacy_lsl_letter.pdf 
Clarifies that limited service labs can continue to operate for 30 days, but must identify a qualified healthcare professional to continue to operate after 30 days.
Vaccine Provider Guidance with Prep Act Footnote: https://coronavirus.health.ny.gov/system/files/documents/2021/06/guidance_for_facilities_receiving_vaccine_6-24-21.pdf  
Recognizes that providers authorized under the PREP Act to vaccinate can continue to administer COVID-19 vaccine in NY.
SED advisory: http://www.op.nysed.gov/COVID-19.html
States that SED will factor into account the termination of the disaster emergency in the event of any potential inquiries involving Title VIII professional activity, and requires professionals to exercise good faith and due diligence in efforts to return to compliance.​

How non-medical private nonprofits can apply for FEMA funding for reimbursement of pandemic-related costs - 6/10/21

Dear New York State Nonprofit Partner,

On March 20, 2020, the State of New York received a Major Disaster Declaration DR-4480 NY from the then President for the COVID-19 Incident. The incident started on January 20, 2020 and is ongoing. The declaration authorizes public assistance for Category B Emergency Protective Measures related to the COVID-19 response. 

To mitigate the pandemic’s impact on nonprofits, New York State is launching a targeted initiative to provide information and training to NON-MEDICAL Private Nonprofits (PNPs) and intermediary organizations applying for FEMA funding to reimburse costs incurred as a direct result of the COVID-19 pandemic. 

PNPs and their umbrella organizations are invited to FEMA overview sessions, hosted by the Division of the Budget (DOB) and the Division of Homeland Security and Emergency Services (DHSES), offering an overview of the FEMA public assistance process as well as a number of COVID-19 disaster specific topics and policies that FEMA has implemented, including new and updated policy and guidance recently released by FEMA. The learning objectives of these sessions are: 

The documentation required and the process working with DHSES to qualify with FEMA as an eligible applicant 
The process by which FEMA determines applicant, facility, work, and expenditure eligibility 
The types of expenditures that non-medical private non-profits would typically incur 
The variances in eligibility of activities and expenditures driven by policy across three distinct time intervals 
Activities and expenses that FEMA considers ineligible for reimbursement and other constraints and limitations applicants must be aware of 
The application process in the FEMA Grants Portal 
For more details on the initiative and related resources, please access the Grants Gateway site. 
To register for the informational overview, see below for next steps or access the Grants Gateway for more information. 

Next Steps

Step 1 

Assess Qualification as a FEMA-Eligible Applicant 
As a PNP you must qualify as an eligible applicant before initiating an application in the FEMA Grants Portal. Both tax-exempt status and facility eligibility must be established first. It is in your best interest to gauge your eligibility as a tax-exempt, qualifying facility before expending effort on an application. DHSES will facilitate this process unless you already have a user account with the FEMA Grants Portal. 
FEMA describes an eligible PNP facility as “one that provides educational, utility, emergency, medical, or custodial care, including for the aged or disabled, and other essential social-type services to the general public.”1 This means that FEMA first determines whether a PNP is eligible to apply based on the type of the facility, the type of ownership as a tax-exempt entity, and the type of services the PNP provides during non-disaster times. 
DHSES provides a so-called Request for Public Assistance (RPA) packet, Private Non-Profit Eligibility (PNP) Guidelines, which steps you through the eligibility assessment along with providing information on required documentation and forms; it is, however, FEMA, which will ultimately determine your eligibility to apply based on the documentation you have submitted. Access the RPA Packet posted here. 
If you, as a PNP, can provide the required documentation, submit the following to DHSES for review and for DHSES to help you access the FEMA Grants Portal. 
To work with DHSES: 
Supply required information to Patricia Debboli so DHSES can establish your Grants Portal Account if you don’t have one already. 
Submit RPA Package Using Option A or B Below: 
A.    If you have a Grants Portal account you can submit at FEMA Grants Portal Website: https://grantee.fema.gov 
B.    Submit to Patricia Debboli @ NYS DHSES: 
E-mail: patricia.debboli@dhses.ny.gov 
Fax: 518-322-4984 
DUNS numbers are required: 
Website: https://fedgov.dnb.com/webform 
Phone: 1-866-705-5711 
1 Federal Emergency Management Agency (FEMA) (2018, April). Public Assistance Program and Policy Guide v3.1 (PAPPG V3.1). Last accessed on 2021, April 10 at https://www.fema.gov/sites/default/files/documents/fema_pappg-v3.1-archived_policy_5-4-2018.pdf. 

Step 2 

Register for FEMA Applicant Overview Sessions for Non-Medical PNPs on FEMA Application Process 
Please click the link(s) below to register for an orientation briefing to learn about FEMA eligibility and the application process based on the date and time most convenient for you. You will receive an email from messenger@webex.com with the login information. 
For comprehensive briefing description, purpose, target audience, and learning objectives, please access the Grants Gateway. In addition, this site offers resources that help you navigate the FEMA application process. 
Please select one of the briefings below to register: 
Session 1 – DR-4480 (COVID-19) Non-Medical Private Nonprofit Applicants Briefing
June 15, 2021, 1:00 – 2:00 PM
- Register - 
Session 2 – DR-4480 (COVID-19) Non-Medical Private Nonprofit Applicants Briefing
June 17, 2021, 1:00 – 2:00 PM
- Register - 
Session 3 – DR-4480 (COVID-19) Non-Medical Private Nonprofit Applicants Briefing
June 22, 2021, 2:00 – 3:00 PM
- Register - 

For questions regarding the orientation sessions, please contact the intermediary organization with which you are associated. For issues or questions regarding signing up for training, as well as any technical questions about Webex, contact the DOB Training Team. 

FDA advises against use of antibody results to evaluate immunity after vaccination - 6/8/21

Recommendations to Resume Use of the Janssen/Johnson & Johnson COVID-19 Vaccine - 5/3/21

NYSDOH COVID-19 Policy for Predrawn Vaccine - 5/3/21

Johnson & Johnson Vaccine Update from NYSDOH - 4/26/21

Statement from Governor Andrew M. Cuomo: 

"World-renowned public health experts from the federal government and our own independent state task force have reviewed the data and reaffirmed that the use of the Johnson & Johnson vaccine can resume. The state of New York will resume administration of this vaccine at all of our state-run sites effective immediately. The vaccine is the weapon that will win the war against COVID and allow everyone to resume normalcy, and we have three proven vaccines at our disposal. I urge every New Yorker to take whichever one is available to them first. The sooner we all get vaccinated, the sooner we can put the long COVID nightmare behind us once and for all." 
Statement from State Health Commissioner Dr. Howard Zucker: 
"Yesterday evening, following a thorough safety review, the CDC and FDA lifted the recommended pause on the COVID-19 Johnson & Johnson vaccine and said that the United States can resume the use of the vaccine for adults, 18 years of age and older. Following discussions with New York State's Clinical Advisory Task Force and Governor Cuomo, I recommend that New York State accept the federal recommendations and resume Johnson & Johnson vaccinations effective immediately. 
"The data has shown the vaccine's known benefits far outweigh the potential and extremely rare risks, but we urge anyone with questions about the COVID-19 vaccines to speak with their healthcare provider. We will continue to communicate regular updates and guidance from the federal government to providers and the general public about the Johnson & Johnson vaccine and all vaccines on the market. 
"We encourage all New Yorker's to get whichever vaccine is available to them, as quickly as possible, so we can finally defeat this virus and continue our path towards fully reopening our communities and economy." 

Following a thorough safety review, including two meetings of the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), the U.S. Food and Drug Administration (FDA) and the CDC have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.
Yesterday afternoon, ACIP voted to reaffirm its original , pre-pause recommendation that “the Janssen COVID-19 vaccine is recommended for persons 18 years of age and older in the U.S. population under the FDA’s Emergency Use Authorization” without any limitations by age, sex or other risk factors.

PLEASE REVIEW FOR IMPORTANT DETAILS: FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review.  Key points from the FDA and CDC regarding this vaccine following a 10-day pause include:

  • Use of the Janssen COVID-19 Vaccine should be resumed in the United States.
  • The FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19.
  • The FDA has determined that the available data show that the vaccine’s known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older.
  • At this time, the available data suggest that the chance of thrombosis-thrombocytopenia syndrome (TTS) occurring is very low, but the FDA and CDC will remain vigilant in continuing to investigate this risk.

The FDA and Janssen have agreed on a warning about thrombosis and thrombocytopenia which will be added to the Janssen COVID-19 vaccine’s Emergency Use Authorization (EUA), and the CDC has created a handout for vaccine recipients about this adverse event.
Health care providers administering the vaccine and vaccine recipients or caregivers should review the  Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Fact Sheet for Recipients and Caregivers, which have been revised to include information about the risk of this syndrome, which has occurred in a very small number of people who have received the Janssen COVID-19 Vaccine.
The Janssen COVID-19 Vaccine Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Fact Sheet for Recipients and Caregivers,, have been have been revised to include information about the risk of this syndrome, which has occurred in a very small number of people who have received the Janssen COVID-19 Vaccine. These new documents MUST be used and are attached and linked above. Please DISCARD any previous versions.

If you currently have Janssen (Johnson & Johnson) COVID-19 vaccine in stock, you may begin to use it immediately.  NYS expects to receive notification from the CDC of a small allocation of this vaccine on Tuesday to be ordered and shipped to providers next week.  For providers enrolled in the New York State (outside of NYC) COVID-19 vaccination program, please submit a weekly planning request by 5:00 PM on Monday, April 26 if you are interested in being considered to receive an allocation of this vaccine next week.
Additional Information:
Agenda and Slides from the ACIP Meeting:
ACIP Meeting Agenda April 23, 2021 (cdc.gov) 
ACIP April 23, 2021 Presentation Slides | Immunization Practices | CDC 
A COCA call will be held early next week in addition to an MMWR release with highlights from the Janssen vaccine discussion. 

NYSACHO Summary of Executive Order - 4/21/21

NYS Vaccine Guidance for Hospitals Discharging to Long-Term Care Facilities - 4/5/21

Updated NYS Travel Guidance - 4/2/21

COVID-19 Travel Advisory | Department of Health (ny.gov)


The travel guidelines require all New Yorkers, as well as those visiting from out-of-state or another country, to take personal responsibility for compliance in the best interest of public health and safety.

Asymptomatic travelers entering New York from another U.S. state or territory are no longer required to test or quarantine as of April 1, 2021. Quarantine, consistent with the CDC recommendations for international travel, is still recommended for domestic travelers who are not fully vaccinated or have not recovered from laboratory confirmed COVID-19 during the previous 3 months. Symptomatic travelers must immediately self-isolate and contact the local health department or their healthcare providers to determine if they should seek COVID-19 testing.

All travelers entering New York from a state that is not a contiguous state who have been outside of New York for more than 24 hours must complete the Traveler Health Form. Contiguous states to New York are Pennsylvania, New Jersey, Connecticut, Massachusetts and Vermont.

Irrespective of quarantine, all travelers must:

  • Monitor symptoms daily from day of arrival in New York through day 14;
  • Continue strict adherence to all recommended non-pharmaceutical interventions, including hand hygiene and the use of face coverings, through Day 14 (even if fully vaccinated); and
  • Must immediately self-isolate if any symptoms develop and contact the local public health authority or their healthcare provider to report this change in clinical status and determine if they should seek testing.

Travelers from Canada, crossing at land borders subject to the agreement between the governments of the United States and Canada, are permitted to travel in accordance with said federal agreement and need not quarantine solely due to such federally authorized travel. Travelers flying between the US and Canada must follow the CDC guidance for international travel.

International Travelers

International travelers arriving in New York must comply with all current CDC requirements for testing and quarantined after international travel.  All travelers must complete the NYS traveler health form.

Upon arrival in the U.S., international travelers must either quarantine for 7 days with a test 3-5 days after travel, or quarantine for the full 10 days without a test.  This requirement applies to all international travelers whether they were tested before boarding, are recovered from a previous COVID-19 infection, or are fully vaccinated. Guidance on how to quarantine can be found here.

Upon arrival in the U.S., travelers must fill out the NYS Department of Health traveler health form to further prevent the spread of COVID-19.

For general inquires contact the call the Hotline: 1-888-364-3065 or Ask a Question.

To file a report of an individual failing to adhere to the quarantine pursuant to the travel guidelines click here or call 1-833-789-0470.

Individuals may also contact their local department of health.

Guidance for Facilities Receiving Vaccine - 3/22/21

Updated NYS Re-distribution Guidance for Local Health Departments - 3/22/21

Do’s and don’ts for talking with patients about coronavirus vaccines - 3/15/21

(AMA) To build COVID-19 vaccine acceptance, it is vital that physicians and health systems communicate effectively. This means using the right words, the right messengers and the right methods to reach diverse audiences. Findings from a national poll help inform physicians and others on the do’s and don’ts of communicating about COVID-19 vaccines.

Click here to read "Do’s and don’ts for talking with patients about coronavirus vaccines" from the American Medical Association (AMA)

NYS guidance for facilities receiving vaccine - 3/10/21

Face coverings opportunity for faith-based and community-based partners - 3/2/21

The following message was released by the Office of Minority Health and Health Disparities Prevention: 
Dear Faith-Based and Community Partners; 
As the response to COVID-19 remains a top priority for us all, we wanted to make you aware of an initiative to increase face mask availability in communities. This opportunity for free face coverings is being offered to faith and community-based partners by the HHS Intergovernmental and External Affairs (IEA)office in collaboration with Office of the Assistant Secretary of Preparedness and Response (ASPR), and in partnership with USPS and the National Council of Textile Organizations. 
To this end we are reaching out to our faith-based and community-based partners to determine your interest in placing an order. 
The face mask details are as follows: 
·       Face masks are 100% Cotton Jersey, bind around face and ear loops, and are treated with a 0.5% OWG Agion AMB-10 Antimicrobial (which is thought to remain on the face mask for up to 15 washings). 
·       They do not replace the N95 face mask used in healthcare settings and should not be used when caring for those with COVID-19. They are intended to expand the community’s capacity to limit the spread of COVID-19. 
·       The face masks come in cartons of 500 masks per carton. A palette contains 45 cartons (22,500 masks).   
·       It may take between 30 to 45 days to receive the face coverings from date of order.  
·       These face masks will be shipped directly to your organization at no cost. Please note that no tracking number or shipping alerts will be provided - so they will be delivered as instructed without notice.  
If your organization would like to participate, please fill out this attached order form and submit to HHSreg2@hhs.gov.
Should you/they have questions about your order after 30 days, email facecoverhhsaspr@hhs.gov and make a direct inquiry.  

Cuomo: 1 million vaccinated in NYS with second dose - 2/15/21

National Governors Association letter to President Biden - 2/15/21

Several Updates from New York State - 2/5/21

OPWDD Extra Dose Clarification from the Governor's Office:

OPWDD allocation is not under the 7-day use it or lose it policy;

·         If Local Health Departments are seeking to re-purpose OPWDD allocations for 1B, you have to document that they have outreached entirely within your county to the OPWDD population and then submit a proposal to DOH and The Hub that outlines how you intend to use the excess doses.

·         Same is true for moving to 65+ population

Homeless Shelters - Is this population a current Priority Group?:

Guidance from NYSACHO:

NYSACHO was able to bring your question on whether all homeless shelters are included for vaccine eligibility or if they are specifically defined to Lora last night. Lora indicate that yes, under OTDA all congregate settings are eligible – any homeless shelter where sleeping, bathing or eating accommodations must be shared with individuals and families from different households. Suggestion is to reach out to your local DSS for locations.

Information from Moderna on transportation of vaccine and subsequent storage requirements.

 Thank you for your request. In response to your unsolicited inquiry: “Subject: Vaccine transport temperature excursion”

Per the Fact Sheet for Healthcare Providers and Full Prescribing Information, thawed vials may be stored under refrigeration between 36 to 46°F for up to 30 days prior to first use or date of expiry, whichever occurs first. Thawed vials should not be refrozen. 

o Moderna does not endorse intentional vaccine storage in any manner that is inconsistent with the Fact Sheet for Healthcare Providers and Full Prescribing Information, which has been attached for your reference.

o Clinical judgment should be exercised when deciding to administer vaccine that has incurred excursion conditions.

o The following in-house stability information is relevant to your inquiry:


·          If the product was between -2°C to < 8°C (28°F to < 46°F) for up to 30 days, (If vials can be visually observed and are visually confirmed frozen), return to -25°C to -15°C (-13°F to 5°F) storage. Use product within published expiry

·         If the product was between -2°C to < 8°C (28°F to < 46°F) for up to 30 days, (If vials cannot be visually observed and excursion is less than 180 minutes), Return to -25°C to -15°C (-13°F to 5°F) storage. Use product within published expiry

The above information is being provided in response to your unsolicited inquiry and is intended for educational purposes only. It should not be altered, duplicated, or further disseminated.


1. Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers): Emergency Use Authorization (EUA) of the Moderna COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19). ModernaTx, Inc. 2020. https://www.modernatx.com/covid19vaccine-eua/eua-fact-sheet-providers.pdf. 

2. Data on file, ModernaTx, Inc., 2020.

Governor Update 2/5 - List of Comorbidities and Underlying Conditions Eligibility - Today's press conference, the Governor  announced that hospitals will have 1 more week to finish up hospitals workers / 1A then the state is going to reallocate majority of 1a hospital worker allocation to Local Health Departments to vaccinate populations with comorbidities beginning 2/15.

The Governor said "local health departments should prepare" and that he is working with CDC to establish the comorbidities list. 


Cancer, Chronic Kidney Disease, Pulmonary Disease, Intellectual and Developmental Disabilities, Heart Conditions, Immunocompromised State, Severe Obesity, Pregnancy, Sickle Cell Disease or Thalassemia, Type 1 or 2 Diabetes Mellitus, Cerebrovascular Disease, Neurologic Conditions and Liver Disease Will Be Eligible

Governor Andrew M. Cuomo today released the list of comorbidities and underlying conditions that New York State will use to determine eligibility for the COVID-19 vaccine. New Yorkers who have one of the comorbidities on the list will be eligible for the vaccine beginning February 15. 

"New Yorkers with comorbidities and underlying conditions exist throughout the state's population—they're our teachers, lawyers and carpenters, in addition to the doctors who keep us safe every day, and they are a highly affected population," Governor Cuomo said. "We're committed to vaccinating vulnerable populations that have suffered the most as we distribute a strictly limited supply of vaccines, and people with comorbidities are 94 percent of the state's COVID deaths. That's why we'll open eligibility to people with comorbidities starting February 15 and give hospitals the ability to use extra doses they have to address that population. Local governments have a week to prepare for the new change—they need to get ready now."

The full list of comorbidities and underlying conditions is available below. The list is subject to change as additional scientific evidence is published and as New York State obtains and analyzes additional state-specific data.

Adults of any age with the following conditions due to increased risk of moderate or severe illness or death from the virus that causes COVID-19:


·         Cancer (current or in remission, including 9/11-related cancers)

·         Chronic kidney disease

·         Pulmonary Disease, including but not limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, and 9/11 related pulmonary diseases

·         Intellectual and Developmental Disabilities including Down Syndrome

·         Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure)

·         Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes

·         Severe Obesity (BMI 40 kg/m2), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2)

·         Pregnancy

·         Sickle cell disease or Thalassemia

·         Type 1 or 2 diabetes mellitus

·         Cerebrovascular disease (affects blood vessels and blood supply to the brain)

·         Neurologic conditions including but not limited to Alzheimer's Disease or dementia

·         Liver disease


Governor Update 2/5:



 As of 11AM today, New York's Health Care Distribution Sites Have Administered 99% of Week 1-7 Allocation and 93% of the Total First Doses Received from Federal Government; Week 8 Allocation Has Begun Arriving  

New Statewide Data Reveals Lower Vaccine Acceptance Rates Among Eligible Black and Latino New Yorkers; ABNY Poll Confirms Hesitancy

 Vaccine Dashboard Will Update Daily to Provide Updates on the State's Vaccine Program; Go to ny.gov/vaccinetracker


Governor Andrew M. Cuomo today updated New Yorkers on the state's vaccination program. As of 11AM today, New York's health care distribution sites have received 1,661,290 first doses and already administered 93 percent or 1,539,355 first dose vaccinations and 80 percent of first and second doses. The week 8 allocation from the federal government continues being delivered to providers for administration this week. New York State health care distribution sites have administered 99% of the full week 1-7 allocation which has been fully delivered to NYS and providers are beginning to administer Week 8 allocations as they arrive.

"From the beginning of the vaccination effort, we have made it clear - our goal is to get shot in arms as quickly and equitably as possible and that's exactly what we are doing," Governor Cuomo said. "While the data shows New York is administering the vaccine at an extremely high rate, the most concerning issue at this point is that there continues to be a reluctance in much of the Black community to take the vaccine. We expected it. We talked about it early on. We are addressing it, but it still exists. Yes, there are bonafide reasons for distrust in the system, but it's not true with this vaccine. The hesitancy must be directly addressed with facts and validation. From partnering with community leaders to help dispel rumors and myths, to establishing vaccination sites directly in underserved communities, like we did with Yankee Stadium, we're doing more in New York than any state in this regard, and we are doubling down on those efforts. In order to finally win this war against COVID, everyone needs to be on board, and we will continue to do everything we can to make that happen."

Additionally, the Governor released new statewide demographic data on the vaccine acceptance rate across eligible populations. A breakdown of the data is as follows:


1A - Hospital Workers

1B - Essential Workers

1B - 65+ Population

63% of vaccine recipients were white (70% of eligible population)

74% of vaccine recipients were white (75% of eligible population)

78% of vaccine recipients were white 77% of eligible population)

10% of vaccine recipients were African American (17% of eligible population)

5% of vaccine recipients were African American (17% of eligible population)

4% of vaccine recipients were African American (13% of eligible population)

10% of vaccine recipients were Hispanic or Latino (9% of eligible population)

10% of vaccine recipients were Hispanic or Latino (14% of eligible population)

5% of vaccine recipients were Hispanic or Latino (12 % of eligible population)

16% of vaccine recipients were Asian (12% of eligible population)

7% of vaccine recipients were Asian (6% of eligible population)

8% of vaccine recipients were Asian (7% of eligible population)

A recent poll conducted by the Association for a Better New York confirms similar trends with increased hesitancy about the vaccine among Black, Hispanic and Asian New Yorkers. The poll found: 78 percent of white New Yorkers would take the vaccine as soon as it was available to them compared 39 percent of Black New Yorkers, 54 percent of Hispanic New Yorkers and 54 percent of Asian New Yorkers who said the same.

Approximately 7 million New Yorkers are currently eligible to receive the vaccine. The federal government has increased the weekly supply by more than 20 percent over the next three weeks, but New York's vast distribution network and large population of eligible individuals still far exceed the supply coming from the federal government. Due to limited supply, New Yorkers are encouraged to remain patient and are advised not to show up at vaccination sites without an appointment.

The state's Vaccine Dashboard includes a county-by-county breakdown for vaccinations administered through the Long Term Care Facility program and vaccine administration progress for hospital workers. Vaccination program numbers below are for doses distributed and delivered to New York for the state's vaccination program, and do not include those reserved for the federal government's Long Term Care Facility program. A breakdown of the data based on numbers reported to New York State as of 11:00 AM today is as follows. The allocation totals below include 33 percent of the week 8 allocation which will finish being distributed to New York provider sites on Sunday.


·         First Doses Received - 1,661,290

·         First Doses Administered - 1,539,355; 93%

·         Second Doses Received - 794,650

·         Second Doses Administered - 413,512



Total Doses Received

(1st and 2nd)

Total Doses Administered

(1st and 2nd)

% of Total Doses Administered/Received

(1st and 2nd)

Capital Region




Central New York




Finger Lakes




Long Island








Mohawk Valley




New York City




North Country




Southern Tier




Western New York











1st doses fully delivered to New York for Healthcare Distribution Sites

2nd doses fully delivered to New York for Healthcare Distribution Sites




Week 1

Doses arriving 12/14 - 12/20









Week 2
Doses arriving 12/21 - 12/27











Week 3

Doses arriving 12/28 - 01/03










Week 4

Doses arriving 01/04 - 01/10













Week 5
Doses arriving 01/11 - 01/17












Week 6

Doses arriving
01/18- 01/24













Week 7

Doses arriving

01/25 - 01/31











Week 8

Doses arriving

02/01 - 02/07*







*These numbers represent 33 percent of the Week 8 allocation. The full Week 8 allocation is expected to arrive by the end of day Sunday, February 7.


To date, New York's health care distribution sites have administered 93 percent of week first doses received from the federal government but due to the federal government's limited allocation, appointments have filled up quickly. New Yorkers seeking to determine eligibility and schedule an appointment at a state-run mass vaccination site, can visit the 'Am I Eligible' website. New Yorkers may also call their local health department, pharmacy, doctor, or hospital for additional information and to schedule appointments where vaccines are available.

The COVID-19 Vaccine Tracker Dashboard is available to update New Yorkers on the distribution of the COVID-19 vaccine. The New York State Department of Health requires vaccinating facilities to report all COVID-19 vaccine administration data within 24 hours; the vaccine administration data on the dashboard is updated daily to reflect the most up-to-date metrics in the state's vaccination effort.

New Yorkers who suspect fraud in the vaccine distribution process can now call 833-VAX-SCAM (833-829-7226) toll-free or email the state Department of Health at STOPVAXFRAUD@health.ny.gov. Hotline staff will route complaints to the appropriate investigative agencies to ensure New Yorkers are not being taken advantage of as the State works to vaccinate the entire eligible population

Vaccine Transport Guidance & Tracking Form - 2/1/21

Updated Redistribution Guidance - 1/23/21

COVID-19 Vaccine Weekly Planning Requests - 1/23/21

NYS guidance for facilities receiving vaccine - 1/15/21

Updates and Clarification - 1/15/21

*The definition of co-morbidities and immunocompromised is under review by DOH and will likely take some time.

*The "use it or lose it" rule is being enforced by NYS. Please continue to use allocations as soon as possible and within the 7 day window

When doses get reallocated, who receives the B dose?  The original owner of the dose, or the receiver of the reallocation?

  • B doses will go to the original entity that received them, and will therefore also need to be redistributed.

Clarification on the scheduling of vaccines issue:

  • We've guaranteed supply for only pharmacies at this point, they should continue to book in advance. We will try to create more stability for providers in the future. 

How do those who fall under the “immunocompromised” category prove, for lack of a better word, that they are so they can get their shot?

  • DOH continues to review the federal guidance on the co-morbidities list, they will make a determine sometime in the future.

Will comorbidity guidance be for all ages or over a certain age + comorbidity?

  • We expect the distinction to apply from 18 - 64 years old.

Are the following eligible in Phase 1B?

  • College security guards and public safety? No (peace officers only)|
  • School cleaners (considered contractors like bus drivers)? No to janitors, yes to bus drivers
  • Fire marshals? Peace officers only
  • Code inspectors? Peace officers only
  • County DSS/OCFS staff? Only if they are direct care in congregate settings
  • OCFS child protective workers? Yes
  • Public defenders? No

Should all providers without vaccine schedule appointments (or just 75+ sites)? Conflicting advice this week from DOH and then Larry/Gov Thursday.

  • Only pharmacies at this time.

Given the lack of vaccine supply this week, do/did we notify providers that pre-booked vaccine but are not receiving any this week?

  • No, we only notify providers that are receiving.

Should providers be specifying separately which populations they want vaccine for?

  • No.

Many providers submitted large, multi-week pre-book order many weeks ago and have been receiving vaccine w/out updating that original pre-booking. Most still haven’t gotten all the 1A vaccine they need/requested. Now that we are focusing week-to-week, are those original pre-book orders still being utilized or should everyone resubmit a pre-book every week for what they still need?

  • No, they should pre-book every week.

In the event a pre-book is not fulfilled any given week, should providers assume those requests remain standing/valid for the next week, or should they enter a new pre-book each week.

  • No, they should pre-book every week.

Is there a day of the week you want pre-booking submitted by?

  • Best practice is to be complete by COB Monday.

Is DOH now requesting or requiring Vx providers to get signed declinations from health care workers that refuse vaccine?

  • No.

Is there guidance on what to do with extra 2nd doses (b/c of appt no-shows or extra vaccine in vials)?

  • Not at this time, but DOH is reviewing the issue.

Do you have a list of providers for our areas that are receiving vaccine? 

  • Hubs should be receiving the weekly allocation list from DOH.

We heard on the 7pm call last night that the hospital is suppose to prioritize the healthcare workers.  How do they do this if they open the link anyone and everyone signs up?

  • We recommend targeting the sharing of the link with specific populations.

If an unemployed volunteer firefighter wants to volunteer to administer vaccine, will that affect his or her unemployment benefits? 

  • Please refer to DOL.

If a hospital is employing long term travel staff from outside the region on a contract basis, they find that when they put their actual address in the vaccination form they are not able to get through. Is there a workaround or should they put the address of the facility in which they work, or the hotel/temp address at which they are staying?

  • They should use the address of the facility they work in.

Is there state guidance on how to deal with empty vaccine vials? We put them in the Sharps containers which are kept locked. We’ve been aware of concerns that people will steal the vials and fill them with something else to pass them off as vaccine and sell them. 

  • Please continue to secure them, guidance is forthcoming. 

Are district attorneys and their employees covered under law enforcement personnel?

  • No.

We have nursing home admits who are now due for 2nd doses, while inpatient. I have been instructing them they should follow-up with the NH where they first were vaccinated but in the case of Rehab patients, they may not be going back to the same facility.  Likewise and based on NH mandates some of these folks could be inpatients for weeks awaiting negative covid tests before we can send them back.  What’s are obligation in these situations?

  • They should work with the hospital to get the second dose, ensuring its the same type of vaccine.